Trials / Completed
CompletedNCT02289261
A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Cukurova University · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether dexmedetomidine added to morphine is effective in the treatment of chronic cancer pain.
Detailed description
We conduct the study in Cukurova University Faculty of Medicine Research Hospital after obtaining ethics committee approval and patient's informed consent. Patients with cancer pain are allocated into two group to receive Patient Controlled Analgesia with morphine or morphine plus dexmedetomidine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Morphine | Morphine, 0.02 mg/kg PCA bolus dose with 10 minutes lock-out interval |
| DRUG | Morphine plus dexmedetomidine | Morphine 0.02 mg/kg plus dexmedetomidine 0.1 microgram/kg PCA bolus dose with 10 minutes lock-out interval |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2014-11-13
- Last updated
- 2018-06-19
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02289261. Inclusion in this directory is not an endorsement.